• Phillygenin Mechanisms in Diabetic Nephropathy

  2026-08-25

  The reference study shows that phillygenin protects against diabetic nephropathy in high-glucose podocytes and db/db mice by suppressing TLR4/MyD88/NF-κB-associated inflammation and apoptosis while restoring PI3K/AKT/GSK3β signaling. Its integrated use of RNA sequencing, molecular validation, and renal phenotyping provides a mechanistic framework for evaluating phillygenin, although translation beyond experimental models remains unresolved.

• SM-102 for Reliable mRNA-LNP Assays

  2026-08-25

  A scenario-based guide to using SM-102 in mRNA delivery workflows while separating formulation effects from cell viability, proliferation, and cytotoxicity readouts. It explains how SKU C1042 specifications, handling, controls, and literature context support more interpretable laboratory decisions.

• HDAC6-Catalyzed α-Tubulin Lactylation

  2026-08-24

  The reference study identifies α-tubulin Lys40 lactylation as a metabolic post-translational modification that increases microtubule dynamics. It further establishes HDAC6 as a lactate-responsive catalytic regulator linking cellular metabolism to neuronal cytoskeletal remodeling, neurite outgrowth, and branching.

• STING agonist-1: Assay Design for B-Cell STING Biology

  2026-08-24

  STING agonist-1 provides a controlled chemical probe for studying STING pathway activation in innate immunity and its connection to B-cell phenotypes. This article translates recent ESCC TLS findings into practical assay decisions while defining controls, endpoints, handling parameters, and interpretive limits.

• HyperScribe All in One mRNA Synthesis Kit Plus 1

  2026-08-23

  Generate ARCA-capped, 5mCTP- and ψUTP-modified, polyadenylated mRNA through a consolidated T7 transcription workflow. The kit connects RNA vaccine development, translation testing, and RNAi experiments while reducing manual handling between capping, DNA removal, and tailing steps.

• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-08-22

  The reference study challenges the prevailing view that AMPK uniformly promotes autophagy during glucose starvation. Its experiments show that AMPK suppresses ULK1-dependent autophagy initiation while preserving autophagy machinery, revealing a context-dependent energy stress response with important implications for metabolic and cell-signaling research.

• WAY-100635: Selective 5-HT1A Antagonist

  2026-08-21

  WAY-100635 is a potent, selective, silent 5-HT1A receptor antagonist for serotonin receptor antagonist research and neuroscience receptor pharmacology. Its binding, functional, behavioral, and imaging-research profiles support use as a mechanistic tool rather than as a therapeutic or diagnostic product.

• Protein A/G Magnetic Co-IP/IP Kit Workflow

  2026-08-21

  Build faster, cleaner immunoprecipitation workflows for protein complexes, antibody purification, and IP–MS discovery. This guide translates AP2-M parasite biology into practical assay design, control selection, and troubleshooting using magnetic separation.

• SmD2 Acetylation Tunes HCC PARP Inhibitor Response

  2026-08-20

  This study identifies the spliceosome core protein SmD2 as an acetylation-regulated determinant of DNA damage repair and PARP inhibitor sensitivity in hepatocellular carcinoma. By linking p300/HDAC2-dependent SmD2 stability to BRCA1 and FANC cassette-exon regulation, the work supports spliceosome-directed combination strategies for HCC, including HDAC and PARP inhibition.

• Machine Learning Detects Senescence in Glioblastoma

  2026-08-20

  A bioRxiv preprint presents an imaging-based machine learning pipeline that recognises senescent glioblastoma cells using only DAPI nuclear staining. By applying the classifier to existing high-throughput drug-screening images and experimentally testing predictions, the study demonstrates a scalable route for identifying senescence-inducing compounds.

• Crizotinib Hydrochloride in Tumor Assembloids

  2026-08-19

  Crizotinib hydrochloride can function as more than an ALK kinase inhibitor in advanced tumor models: it can help separate cancer-cell-intrinsic signaling from stromal protection. This article translates patient-derived gastric cancer assembloid findings into a practical framework for target engagement, response decomposition, and assay design.

• Alosetron in Intestinal Signaling Research

  2026-08-19

  Use Alosetron as a selective 5-HT3 receptor antagonist to separate serotonin-dependent effects on epithelial behavior, gastrointestinal motility modulation, and visceral pain signaling from the CDC42–YAP–mTOR mechanisms that control intestinal stem cell fate. This article provides a practical organoid and epithelial workflow, assay controls, and troubleshooting guidance for hypothesis-driven gastrointestinal research.

• SGC-CBP30 for CREBBP/EP300 Bromodomain Studies

  2026-08-18

  SGC-CBP30 provides a selective chemical handle for testing how CREBBP and EP300 bromodomains influence enhancer-driven transcription, TGF-β/SMAD3 signaling, and cancer phenotypes. This workflow translates the LINC01977 super-enhancer findings into practical chromatin, transcriptional, and functional assays while emphasizing controls and troubleshooting.

• Thrombin B-Chain Fragment: Assay Design Guide

  2026-08-17

  Thrombin B-chain fragment A1057 is a sequence-defined reagent for rigorous protease and molecular assays. This guide explains how to distinguish fragment identity from intact enzyme activity and applies lessons from a SARS-CoV-2 3CLpro screening study to assay design.

• AI-10-49: CBFβ-SMMHC Inhibitor Workflow

  2026-08-17

  AI-10-49 enables mechanism-first studies of inv(16) acute myeloid leukemia by separating CBFβ-SMMHC–RUNX1 target engagement from downstream survival effects. This practical guide connects compound handling, leukemia-cell assays, chromatin immunoprecipitation, transcriptional readouts, and in vivo validation into one troubleshooting-ready workflow.

591 records 1/40 page Next 12345 下5页 Last page